Page 4 - Singm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Singm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Singm Today - Breaking & Trending Today

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Given Consensus Recommendation of "Buy" by Analysts

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM – Get Rating) has received an average recommendation of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have issued ratings on the stock in the […] ....

United States , Hong Kong , Jasper Ridge , Raymond James , Ngm Biopharmaceuticals Inc , Grouplp Column , Biopharmaceuticals Inc , Acadian Asset Management , Goldman Sachs Group , Royal Bank , Hong Kong Ltd , Get Rating , Director Group , State Teachers Retirement System , Kong Ltd , Ngm Biopharmaceuticals , Nasdaq Ngm ,

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Director Group L. P. Column Buys 34,200 Shares

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM – Get Rating) Director Group L. P. Column purchased 34,200 shares of NGM Biopharmaceuticals stock in a transaction dated Thursday, June 2nd. The stock was bought at an average price of $13.03 per share, for a total transaction of $445,626.00. Following the completion of the transaction, the director now directly owns […] ....

Raymond James , Zurcher Kantonalbank Zurich Cantonalbank , Securities Exchange Commission , Ngm Biopharmaceuticals Inc , Goldman Sachs Group Inc , Zacks Investment Research , Grouplp Column , Panagora Asset Management Inc , Biopharmaceuticals Inc , Nisa Investment Advisors , Goldman Sachs Group , Get Rating , Director Group , Exchange Commission , Investment Advisors , Asset Management , Kantonalbank Zurich Cantonalbank , Sachs Group , Ngm Biopharmaceuticals , Nasdaq Ngm , Insider Trading , Nsider Trades ,

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Receives Consensus Recommendation of "Buy" from Analysts

Shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM – Get Rating) have earned an average rating of “Buy” from the seven brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price target among […] ....

Thomson Reuter , Raymond James , Piper Sandler , Biopharmaceuticals Inc , Acadian Asset Management , Zacks Investment Research , Ensign Peak Advisors Inc , Macquarie Group Ltd , Royal Bank , Get Rating , Asset Management , Ngm Biopharmaceuticals , Nasdaq Ngm ,

-$0.42 Earnings Per Share Expected for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) This Quarter

Wall Street analysts forecast that NGM Biopharmaceuticals, Inc. (NASDAQ:NGM – Get Rating) will report earnings of ($0.42) per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for NGM Biopharmaceuticals’ earnings, with the highest EPS estimate coming in at ($0.22) and the lowest estimate coming in at ($0.65). NGM Biopharmaceuticals […] ....

Thomson Reuter , Raymond James , Piper Sandler , Biopharmaceuticals Inc , Stepstone Group , Zacks Investment Research , Blackrock Inc , Biopharmaceuticals Company Profile Get Rating , Millennium Management , Wall Street , Get Rating , Investment Research , Stone Group , Two Sigma Investments , Sigma Investments , Company Profile , Ngm Biopharmaceuticals , Nasdaq Ngm ,

NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Expected to Post Quarterly Sales of $22.35 Million

Analysts expect NGM Biopharmaceuticals, Inc. (NASDAQ:NGM – Get Rating) to report $22.35 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for NGM Biopharmaceuticals’ earnings. The lowest sales estimate is $15.00 million and the highest is $29.69 million. NGM Biopharmaceuticals posted sales of $21.58 million during the same […] ....

United States , Thomson Reuter , Raymond James , Piper Sandler , Schonfeld Strategic Advisors , Zacks Investment Research , Blackrock Inc , Biopharmaceuticals Inc , Biopharmaceuticals Company Profile Get Rating , Barclays Plc , Millennium Management , Get Rating , Investment Research , State Teachers Retirement System , Strategic Advisors , Company Profile , Ngm Biopharmaceuticals , Nasdaq Ngm ,